These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

172 related items for PubMed ID: 6508201

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Impact of intravesical chemotherapy on recurrence rate of recurrent superficial transitional cell carcinoma of the bladder: results of a meta-analysis.
    Huncharek M, McGarry R, Kupelnick B.
    Anticancer Res; 2001; 21(1B):765-9. PubMed ID: 11299841
    [Abstract] [Full Text] [Related]

  • 25. Recurrence, progression and success in stage Ta grade 3 bladder tumors treated with low dose bacillus Calmette-Guerin instillations.
    Lebret T, Bohin D, Kassardjian Z, Herve JM, Molinie V, Barre P, Lugagne PM, Botto H.
    J Urol; 2000 Jan; 163(1):63-7. PubMed ID: 10604315
    [Abstract] [Full Text] [Related]

  • 26. [Results and long-term course of superficial bladder carcinomas treated with local adriamycin. Apropos of 69 cases].
    Iborra I, Mazcuñán F, Monros JL, Ricos JV, Solsona E.
    Arch Esp Urol; 1987 Sep; 40(7):455-60. PubMed ID: 3688987
    [No Abstract] [Full Text] [Related]

  • 27. A 12 versus 6-week course of bacillus Calmette-Guerin prophylaxis for the treatment of high risk superficial bladder cancer.
    Gruenwald IE, Stein A, Rashcovitsky R, Shifroni G, Lurie A.
    J Urol; 1997 Feb; 157(2):487-91. PubMed ID: 8996340
    [Abstract] [Full Text] [Related]

  • 28. Effect of prophylactic treatment with intravesical epirubicin on recurrence of superficial bladder cancer--The 6th Trial of the Japanese Urological Cancer Research Group (JUCRG): a randomized trial of intravesical epirubicin at dose of 20mg/40ml, 30mg/40ml, 40mg/40ml.
    Kuroda M, Niijima T, Kotake T, Akaza H, Hinotsu S, 6th Trial of the Japanese Urological Cancer Research Group.
    Eur Urol; 2004 May; 45(5):600-5. PubMed ID: 15082202
    [Abstract] [Full Text] [Related]

  • 29. Prophylactic effect of triethylenethiophosphoramide on the recurrence rate of superficial bladder tumors.
    Mukamel E, Zitron S, Nissenkorn I, Servadio C.
    Isr J Med Sci; 1980 May; 16(9-10):714-6. PubMed ID: 6776072
    [Abstract] [Full Text] [Related]

  • 30. [Postoperative intravesical installation of tetrahydropyranyl-adriamycin (THP) and cytosine arabinoside (CA) for superficial bladder cancer: clinical results of prophylactic effects on recurrence].
    Hashimoto H, Yachiku S, Watabe Y, Niibori D, Yamauchi K, Osanai H, Ohashi K, Wakabayashi A, Fujisawa M.
    Gan To Kagaku Ryoho; 1994 May; 21(6):833-8. PubMed ID: 8185341
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. [Prognostic significance of dysplastic urothelial changes for the rate of recurrence in superficial urinary bladder cancer].
    Flamm J.
    Z Urol Nephrol; 1987 Nov; 80(11):641-6. PubMed ID: 3439374
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. [Prophylactic effect of pirarubicin (THP) on postoperative recurrence of superficial bladder cancer in terms of intravesical retention time].
    Nonomura N, Nishimura K, Okuyama A, Miki T, Kishimoto T, Kiyohara H, Wakatsuki A, Fujioka H, Kuroda H, Nakano E, Takeyama M, Koide T, Yamaguchi S.
    Hinyokika Kiyo; 2001 May; 47(5):315-9. PubMed ID: 11433751
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. [A course of pirarubicin vesical irrigation at thirty mg effectively prevents post-TUR recurrence of superficial bladder cancer].
    Kawamura S, Fujioka T, Kubo T, Yoshida I, Takata K.
    Gan To Kagaku Ryoho; 1996 Mar; 23(4):465-70. PubMed ID: 8678499
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.